Gastro-oesophageal reflux disease: symptoms, erosions, and Barrett’s—what is the interplay?
暂无分享,去创建一个
[1] S. Kihara,et al. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn’s disease , 2005, Gut.
[2] P. Malfertheiner,et al. Prognostic influence of Barrett’s oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study , 2005, Gut.
[3] P. Muller,et al. Translocation of p21Cip1/WAF1 from the nucleus to the cytoplasm correlates with pancreatic myofibroblast to fibroblast cell conversion , 2005, Gut.
[4] Y. Yamaji,et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study , 2005, Gut.
[5] H. Ubukata,et al. A case of untreated gastric cancer followed for 7 years. , 2004, Gastrointestinal endoscopy.
[6] A. Masamune,et al. A c-Jun NH2-Terminal Kinase Inhibitor SP600125 (Anthra[1,9-cd]pyrazole-6 (2H)-one) Blocks Activation of Pancreatic Stellate Cells , 2004, Journal of Pharmacology and Experimental Therapeutics.
[7] A. Beaudet,et al. Leukocyte migration in adipose tissue of mice null for ICAM-1 and Mac-1 adhesion receptors. , 2004, Obesity research.
[8] R. Busse,et al. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. , 2004, Diabetes.
[9] F. Pace,et al. Gastroesophageal Reflux Disease: A Typical Spectrum Disease (A New Conceptual Framework is Not Needed) , 2004, American Journal of Gastroenterology.
[10] M. Lazar,et al. Inflamed about obesity , 2004, Nature Medicine.
[11] M. Boscaro,et al. Adipose Tissue as an Endocrine Organ? A Review of Recent Data Related to Cardiovascular Complications of Endocrine Dysfunctions , 2004, Clinical and experimental hypertension.
[12] M. Desai,et al. Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.
[13] L. Tartaglia,et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.
[14] S. Kihara,et al. Obesity, adiponectin and vascular inflammatory disease , 2003, Current opinion in lipidology.
[15] J. Galmiche,et al. Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases. , 2003, Gastroenterologie clinique et biologique.
[16] R. Henry,et al. Adiponectin: more than just another fat cell hormone? , 2003, Diabetes care.
[17] Philippe Froguel,et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.
[18] J. Virtamo,et al. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[19] D. Loskutoff,et al. Monocyte chemoattractant protein 1 in obesity and insulin resistance , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] Mireille André,et al. Preadipocyte Conversion to Macrophage , 2003, The Journal of Biological Chemistry.
[21] Pedro Iglesias,et al. The role of the novel adipocyte-derived hormone adiponectin in human disease. , 2003, European journal of endocrinology.
[22] M. Taguchi,et al. Oleic Acid-Induced Pancreatitis Alters Expression of Transforming Growth Factor-&bgr;1 and Extracellular Matrix Components in Rats , 2003, Pancreas.
[23] J. Auwerx,et al. Role of peroxisome proliferator-activated receptor γ and retinoid X receptor heterodimer in hepatogastroenterological diseases , 2002, The Lancet.
[24] S. Uchida,et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature Medicine.
[25] H. Yoshikawa,et al. Cytoplasmic p21Cip1/WAF1 regulates neurite remodeling by inhibiting Rho-kinase activity , 2002, The Journal of cell biology.
[26] A. Masamune,et al. Alcohol activates activator protein-1 and mitogen-activated protein kinases in rat pancreatic stellate cells. , 2002, The Journal of pharmacology and experimental therapeutics.
[27] M. Matsuda,et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.
[28] G. Marinos,et al. Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection. , 2002, Liver.
[29] M. Korsten,et al. Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis , 2002, Gut.
[30] D. Johnson,et al. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis , 2002, American Journal of Gastroenterology.
[31] T. Yao. [Inflammatory bowel diseases]. , 2002, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.
[32] E. Furth,et al. An open-label trial of the PPARγ ligand rosiglitazone for active ulcerative colitis , 2001, American Journal of Gastroenterology.
[33] K. McColl,et al. Helicobacter pylori and reflux disease , 2001, The Lancet.
[34] P. Kahrilas,et al. Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients , 2001, American Journal of Gastroenterology.
[35] A. Helicobacter,et al. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts , 2001, Gut.
[36] P. Moayyedi. Dyspepsia: The Clinical Consequences. , 2001 .
[37] H. Lodish,et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[38] A. Oshima,et al. Natural history of early gastric cancer: a non-concurrent, long term, follow up study , 2000, Gut.
[39] B. Staels,et al. Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation , 2000, Inflammation Research.
[40] G. Falk,et al. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial , 2000, Alimentary pharmacology & therapeutics.
[41] R. Ahima,et al. Adipose Tissue as an Endocrine Organ , 2006, Obesity.
[42] NoriyukiOuchi,et al. Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-&kgr;B Signaling Through a cAMP-Dependent Pathway , 2000, Circulation.
[43] P. Pederzoli,et al. Collagen type I synthesized by pancreatic periacinar stellate cells (PSC) co‐localizes with lipid peroxidation‐derived aldehydes in chronic alcoholic pancreatitis , 2000, The Journal of pathology.
[44] D. Jewell,et al. The relationship between inflammatory and serosal connective tissue changes in ileal Crohn's disease: evidence for a possible causative link , 2000, The Journal of pathology.
[45] T Nakamura,et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. , 1999, Circulation.
[46] J S Wilson,et al. Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. , 1999, The American journal of pathology.
[47] J. Auwerx,et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. , 1999, Gastroenterology.
[48] P. Malfertheiner,et al. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. , 1999, Gastroenterology.
[49] S. Friedman,et al. Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy , 1999, Journal of gastroenterology and hepatology.
[50] K. Miyazono,et al. Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation , 1999, The EMBO journal.
[51] P. Malfertheiner,et al. Role of aging in the expression of Helicobacter pylori gastritis in the antrum, corpus, and cardia. , 1999, Scandinavian journal of gastroenterology.
[52] S. Coppack,et al. Adipose tissue as an endocrine and paracrine organ , 1998, International Journal of Obesity.
[53] J. Fraumeni,et al. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.
[54] R. Schmid,et al. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. , 1998, Gastroenterology.
[55] R. Sampliner,et al. Short segment Barrett's esophagus—the need for standardization of the definition and of endoscopic criteria , 1998, American Journal of Gastroenterology.
[56] G. Griffioen,et al. Is Barrett's esophagus characterized by more pronounced acid reflux than severe esophagitis? , 1998, American Journal of Gastroenterology.
[57] M. Korsten,et al. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture , 1998, Gut.
[58] J. Levine,et al. Adipocyte macrophage colony-stimulating factor is a mediator of adipose tissue growth. , 1998, The Journal of clinical investigation.
[59] K. Umesono,et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. , 1998, The Journal of clinical investigation.
[60] Philipp E. Scherer,et al. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor , 1998, Current Biology.
[61] J. Ferlay,et al. Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.
[62] M. Fujimiya,et al. Morphological and Immunocytochemical Identification of Periacinar Fibroblast‐like Cells Derived from Human Pancreatic Acini , 1997, Pancreas.
[63] B. Spiegelman,et al. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. , 1996, Molecular endocrinology.
[64] S. Yamashita,et al. Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty , 1996, Nature Medicine.
[65] B. Baxter,et al. Transforming growth factor-beta 1 inhibits human arterial smooth-muscle cell proliferation in a growth-rate-dependent manner. , 1995, American journal of surgery.
[66] A. Shar,et al. Quantitative endoscopy: precise computerized measurement of metaplastic epithelial surface area in Barrett's esophagus. , 1995, Gastroenterology.
[67] P. Nyström,et al. Intraoperative enteroscopy in Crohn's disease , 1993, The British journal of surgery.
[68] S. Friedman. The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies , 1993 .
[69] N. Shepherd,et al. Fat‐wrapping in Crohn's disease: Pathological basis and relevance to surgical practice , 1992, The British journal of surgery.
[70] R. Diegelmann,et al. Transforming growth factor beta 1 selectively augments collagen synthesis by human intestinal smooth muscle cells. , 1990, Gastroenterology.
[71] T. Ledin,et al. The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. , 1989, Scandinavian journal of gastroenterology.
[72] C. McConkey,et al. Gastric cancer: A 25‐year review , 1989, The British journal of surgery.
[73] J. Rotter,et al. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. , 1982, Gastroenterology.
[74] G. Oppenheimer,et al. Regional ileitis; a pathologic and clinical entity. , 1952, The American journal of medicine.
[75] 田中 啓之. Cytoplasmic p21Cip1/WAF1 regulates neurite remodeling by inhibiting Rho-kinase activity , 2005 .
[76] A. Masamune,et al. A c-Jun N-terminal Kinase Inhibitor SP600125 Blocks Activation of Pancreatic Stellate Cells , 2004 .
[77] L. Pénicaud,et al. Preadipocyte conversion to macrophage: evidence of plasticity , 2002 .
[78] Cancer incidence in five continents. Volume VIII. , 2002, IARC scientific publications.
[79] R. P. Blankfield,et al. Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.
[80] E. Furth,et al. An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis. , 2001, The American journal of gastroenterology.
[81] A. Greenberg,et al. The short- and long-term effects of tumor necrosis factor-alpha and BRL 49653 on peroxisome proliferator-activated receptor (PPAR)gamma2 gene expression and other adipocyte genes. , 1998, Molecular endocrinology.
[82] S. Friedman. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. , 1993, The New England journal of medicine.
[83] R. Uibo,et al. Chronic gastritis: progression of inflammation and atrophy in a six-year endoscopic follow-up of a random sample of 142 Estonian urban subjects. , 1991, Scandinavian journal of gastroenterology. Supplement.